Eastgate Biotech Corp. (ETBI)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 23, 2025
-98.89%
Market Cap 4.23M
Revenue (ttm) 137.64K
Net Income (ttm) -3.82M
Shares Out 1.06B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,500
Average Volume 179,960
Open 0.0045
Previous Close n/a
Day's Range 0.0001 - 0.0045
52-Week Range 0.0000 - 0.0045
Beta -3,790.01
RSI 52.93
Earnings Date n/a

About Eastgate Biotech

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions contai... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1999
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol ETBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.